Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$102.19 USD
+0.45 (0.44%)
Updated May 31, 2024 04:03 PM ET
After-Market: $102.20 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Brokerage Reports
Abbott Laboratories [ABT]
Reports for Purchase
Showing records 401 - 420 ( 526 total )
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Stable - improved growth prospects and increasing Emerging Markets mix augur well
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Management raises mid-point of CY14 EPS guidance range - expects strong double-digit EPS growth for CY14 and ahead...
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Management reiterates guidance of strong earnings growth of 10%, going forward, with performance in CY14 expected to be back-end loaded towards H2CY14....
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Management guides for strong earnings growth of 10%, going forward, with performance in CY14
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Strong demand for diagnostic products, cost cutting & lower tax rate help deliver better than expected performance in Q3 CY13
Provider: FIRST GLOBAL
Analyst: THOMAS K